These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 7210858

  • 1. Cancer trends: the potential of radiation modifiers.
    Elkon D.
    Va Med; 1981 Feb; 108(2):120-4. PubMed ID: 7210858
    [No Abstract] [Full Text] [Related]

  • 2. [Restorative inhibition of radiation injureis by chemical compounds as a method of increasing the effectiveness of the radiotherapy of tumors].
    Pelevina II.
    Med Radiol (Mosk); 1977 Feb; 22(2):8-13. PubMed ID: 859396
    [No Abstract] [Full Text] [Related]

  • 3. Response to "Radiation therapeutic gain and Asian botanicals," by Stephen Sagar.
    Lawenda BD.
    Integr Cancer Ther; 2010 Mar; 9(1):14-5. PubMed ID: 20308083
    [Abstract] [Full Text] [Related]

  • 4. Radiation modifiers: treatment overview and future investigations.
    Thomas CT, Ammar A, Farrell JJ, Elsaleh H.
    Hematol Oncol Clin North Am; 2006 Feb; 20(1):119-39. PubMed ID: 16580560
    [Abstract] [Full Text] [Related]

  • 5. Radiobiological modifiers in clinical radiation oncology: current reality and future potential.
    Allison RR.
    Future Oncol; 2014 Dec; 10(15):2359-79. PubMed ID: 25525845
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Modification of radiation damages (author's transl)].
    Antoku S.
    Fukuoka Igaku Zasshi; 1982 Feb; 73(2):71-5. PubMed ID: 7095724
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Conference on chemical modification: radiation and cytotoxic drugs. Key Biscayne, Florida, 17-20 September, 1981.
    Int J Radiat Oncol Biol Phys; 1982 Feb; 8(3-4):323-815. PubMed ID: 7107349
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Assessment of chlorpromazine as radiation sensitizer and protector.
    Huilgol NG, Chatterjee N, Singh BB.
    Indian J Cancer; 1996 Dec; 33(4):195-200. PubMed ID: 9255000
    [Abstract] [Full Text] [Related]

  • 18. [Radiomodifiers and the progress of radiation oncology].
    Iarmonenko SP.
    Vopr Onkol; 1995 Dec; 41(2):93-4. PubMed ID: 7483456
    [No Abstract] [Full Text] [Related]

  • 19. Cytoprotection for radiation-associated normal tissue injury.
    Mao J, Fatunase OA, Marks LB.
    Cancer Treat Res; 2008 Dec; 139():307-27. PubMed ID: 18236722
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.